Accessibility Menu
 
Aeolus Pharmaceuticals logo

Aeolus Pharmaceuticals

(OTC) AOLS

Current Price$0.00
Market Cap$15,200
Since IPO (1996)-100%
5 Year-99%
1 Year+0%
1 Month+0%

Aeolus Pharmaceuticals Financials at a Glance

Market Cap

$15,200

Revenue (TTM)

$771.00K

Net Income (TTM)

$4.09M

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

-57.40 (Low)

Price

$0.00

Volume

4,999

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.00

AOLS News

No articles available.

AOLS: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Aeolus Pharmaceuticals

Industry

Pharmaceuticals

Headquarters

Mission Viejo, CA 92691, US

AOLS Financials

Key Financial Metrics (TTM)

Gross Margin

-39%

Operating Margin

-2%

Net Income Margin

-2%

Return on Equity

0%

Return on Capital

-1%

Return on Assets

-85%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$15.20K

Shares Outstanding

152.09M

Volume

5.00K

Short Interest

0.00%

Avg. Volume

211.459

Financials (TTM)

Gross Profit

$805.00K

Operating Income

$3.27M

EBITDA

$3.27M

Operating Cash Flow

$3.11M

Capital Expenditure

$0.00

Free Cash Flow

$3.11M

Cash & ST Invst.

$3.15M

Total Debt

$0.00

Aeolus Pharmaceuticals Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Currently no data to display.

Quarterly Performance

Name
Q3 2017YOY CHG

Revenue

$13.00K

-98.0%

Gross Profit

$412.00K

-68.9%

Gross Margin

-31.69%

N/A

Market Cap

$15.20K

N/A

Market Cap/Employee

$3.80K

N/A

Employees

4

N/A

Net Income

$949.00K

-8.8%

EBITDA

$949.00K

-8.8%

Quarterly Fundamentals

Name
Q3 2017YOY CHG

Net Cash

$403.00K

-89.3%

Accounts Receivable

$313.00K

-57.8%

Inventory

$0.00

-100.0%

Long Term Debt

$0.00

N/A

Short Term Debt

$0.00

N/A

Return on Assets

-85.39%

N/A

Return on Invested Capital

-1.02%

N/A

Free Cash Flow

$578.00K

+23.2%

Operating Cash Flow

$578.00K

+23.2%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
HCANFHalo Collective Inc.
$0.00+0.00%
RGINRegenicin, Inc.
$0.00+0.00%
VOQPVioQuest Pharmaceuticals, Inc.
$0.00+0.00%
MPXOFMPX International Corporation
$0.00+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
CMCSAComcast
$29.02+0.00%
TQQQProShares Trust - ProShares UltraPro Qqq
$43.08-0.06%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$7.82+0.06%
INFYInfosys
$13.12+0.01%

Questions About AOLS

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.